nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

01.03.2013 | General Gynecology

Aberrant histone acetylation and methylation levels in woman with endometriosis

verfasst von: Xia Xiaomeng, Zhao Ming, Ma Jiezhi, Fang Xiaoling

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the alterations in histone modifications in woman with endometriosis.

Methods

Global histone H3/H4 acetylation and H3K4/H3K9 methylation in eutopic and ectopic endometrium from 15 endometriosis patients were assayed using the EpiQuik™ global histone H3/H4 acetylation and H3K4/H3K9 methylation assay kits. Quantitative real-time reverse transcriptase-polymerase chain reaction was applied to measure mRNA levels of 12 members of histone-related chromatin modifier genes.

Results

Histone H4 hypoacetylation was detected both in eutopic and ectopic endometrium. There were no difference between patients with endometriosis and controls on global levels of H3 acetylation. Furthermore, global histone H3K4 hypomethylation and H3K9 hypomethylation were detected both in ectopic and eutopic endometrium (p < 0.001), and in ectopic endometrium (p < 0.001), respectively. SIRT1 mRNA level was significantly decreased in eutopic endometrium, while mRNA levels of HDAC1, SUV39H1, SUV39H2 and G9a were significantly downregulated in ectopic endometrium. HDAC2 mRNA level was significantly increased in eutopic endometrium. PCAF mRNA level was significantly increased in ectopic endometrium.

Conclusions

Aberrant histone modification may play an important role in the pathogenesis of endometriosis.

Giudice LC, Kao LC (2004) Endometriosis. Lancet 364:1789–1799PubMedCrossRef

Eskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24:235–258PubMedCrossRef

Wheeler JM (1989) Epidemiology of endometriosis-associated infertility. J Reprod Med 34:41–46PubMed

Gurates B, Bulun SE (2003) Endometriosis: the ultimate hormonal disease. Semin Reprod Med 21:125–134PubMedCrossRef

Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S (2002) Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci 955:75–85 (discussion 86–88, 396–406)PubMedCrossRef

Paul DW, Braun DP (2004) Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 18:245–263CrossRef

Ulukus M, Arici A (2005) Immunology of endometriosis. Minerva Ginecol 57:237–248PubMed

Barlow DH, Kennedy S (2005) Endometriosis: new genetic approaches and therapy. Annu Rev Med 56:345–356PubMedCrossRef

Simpson JL, Bischoff FZ, Kamat A, Buster JE, Carson SA (2003) Genetics of endometriosis. Obstet Gynecol Clin North Am 30:21–40PubMedCrossRef

10.

Rier SE (2002) The potential role of exposure to environmental toxicants in the pathophysiology of endometriosis. Ann N Y Acad Sci 955:201–212 (discussion 230–2, 396–406)PubMedCrossRef

11.

Guo SW (2009) Epigenetics of endometriosis. Mol Hum Reprod 15:587–607PubMedCrossRef

12.

Rodenhiser D, Mann M (2006) Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174:341–348PubMed

13.

Vialou V (2010) Histone acetylation, gene regulation and depression. Med Sci (Paris) 26:465–467CrossRef

14.

Schubeler D, Lorincz MC, Cimbora DM, Telling A, Feng YQ, Bouhassira EE, Groudine M (2000) Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol 20:9103–9112PubMedCrossRef

15.

Peterson CL, Laniel MA (2004) Histones and histone modifications. Curr Biol 14:R546–R551PubMedCrossRef

16.

Costa FF (2008) Non-coding RNAs, epigenetics and complexity. Gene 410:9–17PubMedCrossRef

17.

Verdone L, Agricola E, Caserta M, Di Mauro E (2006) Histone acetylation in gene regulation. Brief Funct Genomic Proteomic 5:209–221PubMedCrossRef

18.

Wu Y, Strawn E, Basir Z, Halverson G, Guo SW (2007) Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 87:24–32PubMedCrossRef

19.

Wu Y, Halverson G, Basir Z, Strawn E, Yan P, Guo SW (2005) Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 193:371–380PubMedCrossRef

20.

Yang J, Fang X (2012) Expression of DNMT1, DNMT3a, and DNMT3b in eutopic endometrium. Zhong Nan Da Xue Xue Bao Yi Xue Ban 37:94–99PubMed

21.

Li JX, Liu HL (2004) The relationship of DNA methylation and histone methylation. Yi Chuan 26:267–270PubMed

22.

Tariq M, Paszkowski J (2004) DNA and histone methylation in plants. Trends Genet 20:244–251PubMedCrossRef

23.

Ebert A, Lein S, Schotta G, Reuter G (2006) Histone modification and the control of heterochromatic gene silencing in Drosophila. Chromosom Res 14:377–392CrossRef

24.

Bird A (2001) Molecular biology. Methylation talk between histones and DNA. Science 294:2113–2115PubMedCrossRef

25.

Ruthenburg AJ, Allis CD, Wysocka J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25:15–30PubMedCrossRef

26.

Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T, Carney D, Pena P, Lan F, Kaadige MR, Lacoste N, Cayrou C, Davrazou F, Saha A, Cairns BR, Ayer DE, Kutateladze TG, Shi Y, Cote J, Chua KF, Gozani O (2006) ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442:96–99PubMedCrossRef

27.

Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, Shinkai Y, Allis CD (2003) Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 12:1591–1598PubMedCrossRef

28.

Eskeland R, Eberharter A, Imhof A (2007) HP1 binding to chromatin methylated at H3K9 is enhanced by auxiliary factors. Mol Cell Biol 27:453–465PubMedCrossRef

29.

Smallwood A, Esteve PO, Pradhan S, Carey M (2007) Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev 21:1169–1178PubMedCrossRef

30.

Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, Peters AH (2003) Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13:1192–1200PubMedCrossRef

31.

Santos-Rosa H, Caldas C (2005) Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 41:2381–2402PubMedCrossRef

32.

Vigano P, Somigliana E, Chiodo I, Abbiati A, Vercellini P (2006) Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Hum Reprod Updat 12:77–89CrossRef

33.

Vigushin DM, Coombes RC (2002) Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13:1–13PubMedCrossRef

34.

Mahlknecht U, Hoelzer D (2000) Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med 6:623–644PubMed

35.

Kawano Y, Nasu K, Li H, Tsuno A, Abe W, Takai N, Narahara H (2011) Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod 26:2486–2498PubMedCrossRef

36.

Park JH, Jung Y, Kim TY, Kim SG, Jong HS, Lee JW, Kim DK, Lee JS, Kim NK, Kim TY, Bang YJ (2004) Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin Cancer Res 10:5271–5281PubMedCrossRef

37.

Minucci S, Pelicci PG (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6:38–51PubMedCrossRef

38.

Colon-Diaz M, Baez-Vega P, Garcia M, Ruiz A, Monteiro JB, Fourquet J, Bayona M, Alvarez-Garriga C, Achille A, Seto E, Flores I (2012) HDAC1 and HDAC2 are differentially expressed in endometriosis. Reprod Sci 19:483–492PubMedCrossRef

39.

Imesch P, Samartzis EP, Schneider M, Fink D, Fedier A (2011) Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertil Steril 95:1579–1583PubMedCrossRef

40.

Imesch P, Fink D, Fedier A (2010) Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertil Steril 94:2838–2842PubMedCrossRef

41.

Trapp J, Jung M (2006) The role of NAD⁺ dependent histone deacetylases (sirtuins) in ageing. Curr Drug Targ 7:1553–1560CrossRef

42.

Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N, Murphy MM, Appella E, Alt FW (2005) Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2:67–76PubMedCrossRef

43.

Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137–148PubMedCrossRef

44.

Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappa B-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369–2380PubMedCrossRef

45.

Defrere S, Gonzalez-Ramos R, Lousse JC, Colette S, Donnez O, Donnez J, Van Langendonckt A (2011) Insights into iron and nuclear factor-kappa B (NF-kappa B) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol 26:1083–1092PubMed

Titel: Aberrant histone acetylation and methylation levels in woman with endometriosis
verfasst von: Xia Xiaomeng
Zhao Ming
Ma Jiezhi
Fang Xiaoling
Publikationsdatum: 01.03.2013
Verlag: Springer-Verlag
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 3/2013
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-012-2591-0

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Aberrant histone acetylation and methylation levels in woman with endometriosis

Abstract

Objective

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Sequential clomiphene citrate/hMG versus hMG for ovulation induction in clomiphene citrate-resistant women

Unexpected malignancies after laparoscopic-assisted supracervical hysterectomies (LASH): an analysis of 1,584 LASH cases

Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine

Delivery outcomes in women undergoing elective labor induction at term

Optimal cervical cytology mass screening interval for cervical cancer

MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie